Conferences and Meetings on Oncology

Conference-Service.com offers, as part of our business activities, a directory of upcoming scientific and technical meetings. The calendar is published for the convenience of conference participants and we strive to support conference organisers who need to publish their upcoming events. Although great care is being taken to ensure the correctness of all entries, we cannot accept any liability that may arise from the presence, absence or incorrectness of any particular information on this website. Always check with the meeting organiser before making arrangements to participate in an event!

Meeting organisers can submit meetings free of charge for inclusion into the listing.

ALL COUNTRIES

1.
 
NEO 16 — “New and Emerging Trends In Oncology 2016?
ID
738352
Dates
10 Feb 2016 - 12 Feb 2016
Location
Hyderabad, India
Abstract
The International Conference “New and Emerging Trends In Oncology 2016? (NE0’16) is an initiative by Herbert Publications to provide a unique multidisciplinary environment for all science and research professionals with a common interest in Cancer to navigate, discuss, inform and educate themselves about this evolving disease landscape.
Topics
Cancer Biology Organ Specific Cancer Anti Cancer Drugs Radiation Therapy Cancer Markers Cancer Immunology
2.
 
Noncoding RNAs in Health and Disease
ID
740020
Dates
21 Feb 2016 - 24 Feb 2016
Location
Santa Fe, United States
Abstract
Over the past decade, there has been a greater understanding of genomic complexity in eukaryotes ushered in by the immense technological advances in high-throughput sequencing of DNA and its corresponding RNA transcripts. This has resulted in the realization that beyond protein-coding genes, there are a large number of transcripts that do not encode for proteins and, therefore, may perform their function through RNA sequences and/or through secondary and tertiary structural determinants. This Keystone Symposia meeting is focused on the latest findings concerning different classes of noncoding RNAs that use different strategies to regulate transcription. These are exciting times for discovering the biological scope and the mechanism of action for these RNA molecules, which have roles in dosage compensation, imprinting, enhancer function and transcriptional regulation, with a consequently great impact in development and disease. This meeting is being held jointly with  Enhancer Malfunction in Cancer.
Related subject(s)
3.
 
Enhancer Malfunction in Cancer
ID
740063
Dates
21 Feb 2016 - 24 Feb 2016
Location
Santa Fe, United States
Abstract
Why point mutations in a general transcription factor are associated with specific forms of human malignancies has been a major question in cancer biology. Enhancers are DNA regulatory elements that can be transcribed and are key regulators of tissue-specific gene expression in development; their malfunction through point mutations in either regulatory elements or factors modulating enhancer-promoter communication could result in development problems. Indeed, recent genome-wide studies in the cataloging of somatic mutations in cancer have identified mutations in intergenic sequences encoding regulatory elements and in specific transcription factors that function in enhancer-promoter communication. This Keystone Symposia meeting will review recent reports in this regard and discuss the concept of enhancer malfunction in the misregulation of gene expression in development and in disease pathogenesis. This meeting is being held jointly with  Noncoding RNAs in Health and Disease.
Related subject(s)
4.
 
New Frontiers in Understanding Tumor Metabolism
ID
740084
Dates
21 Feb 2016 - 25 Feb 2016
Location
Banff, Canada
Abstract
This meeting will bring together experts in the field as well as newcomers, who are expected to enrich the conceptual framework for the study of tumor metabolism. Sessions are designed to bring the latest in basic biochemical work in metabolism to biologists, to deliver new findings in oncogenic transcriptional and post-transcriptional regulation of metabolism as a basis for further basic biochemical discoveries, and to provide foundational findings that lead to therapeutic applications of tumor metabolism research. The goals of these sessions are to: 1) Discuss new discoveries of previously unsuspected metabolic re-wiring in cancer, 2) Present current findings in transcriptional and post-transcriptional regulation of tumor metabolism and future challenges, and 3) Provide an update on opportunities for cancer therapy using knowledge generated from fundamental discoveries. New methods and knowledge will be shared at the meeting. This meeting is being held jointly with  Immunometabolism in Immune Function and Inflammatory Disease.
5.
 
Immunometabolism in Immune Function and Inflammatory Disease
ID
740083
Dates
21 Feb 2016 - 25 Feb 2016
Location
Banff, Canada
Abstract
It is now evident that an integral component of immune regulation is through the metabolic pathways necessary to support energetically demanding protective or pathogenic responses. Deciphering these links in the emerging field of immunometabolism is critical to understanding basic immune function. Activation, differentiation and function of M1 & M2 macrophages, Th1, Th2, Th17 & T regulatory T cells as well as effector and memory CD8 T cells are all inexorably linked to pathways that regulate cellular metabolism. Likewise, systemic metabolism and metabolic diseases are very much influenced by immunity, as the metabolic syndrome in obesity is mediated in part by dysregulated immune cells similar to inflammatory and autoimmune disease states. This meeting addresses how immune cells and functions rely upon and are controlled by specific metabolic pathways and nutrient availability and will bridge systemic and cellular metabolic regulation of immune function. Metabolic reprogramming in the activation of adaptive and innate immune cells and the regulation and role of specific metabolic programs in distinct lymphocyte or macrophage subsets will be addressed. The conference will also present new findings on signaling pathways and the influence of immune cell metabolism on anti-tumor immunity, autoimmunity and metabolic diseases. It is anticipated this meeting will be of broad interest to the immunology and metabolic communities. The focus of this meeting on how factors that influence immune cell metabolism impact a variety of inflammatory disorders will provide new fundamental insight into normal immune function as well as opportunities to treat immunological and metabolic diseases. This meeting is being held jointly with  New Frontiers in Understanding Tumor Metabolism.
Related subject(s)
6.
 
Precision: Breast Cancer World Summit 2016
ID
764696
Dates
23 Feb 2016 - 24 Feb 2016
Location
Boston, United States
Abstract
Over the two days, this exclusive summit will bring together 80-100 senior level attendees from the pharmaceutical industry and academia to discuss the most crucial challenges in the development of targeted therapies in Breast Cancer.
Contact
Grace Hamilton;     Email: contact@neo-synth.com
Topics
Antibody Constructs, Antibody Drug Conjugates, Immuno-Oncology, Biomarkers and Companion Diagnostics.
7.
 
DKK 2016 — 32. Deutscher Krebskongress Berlin 2016
ID
746308
Dates
24 Feb 2016 - 27 Feb 2016
Location
Berlin, Germany
Abstract
Der Deutsche Krebskongress (DKK) ist der größte und bedeutendste Fachkongress zur Krebsdiagnostik und Krebstherapie im deutschsprachigen Raum. Er wird von der Deutschen Krebsgesellschaft und der Deutschen Krebshilfe gemeinsam ausgerichtet.

- Aktuelles zu allen häufigen und vielen seltenen

Krebserkrankungen

- Vorstellung aller neuen Leitlinien

- Interaktive Tumorkonferenzen

- Aktuelle gesundheitspolitische Themen

Contact
Kongress- und Kulturmanagement GmbH;     Phone: [+49 3643 2468-0];     Email: info@kukm.de
Topics
Kongressmotto: MEDIZIN HEUTE: präventiv, personalisiert, präzise und partizipativ
Event website
8.
 
12th UC San Diego Moores Cancer Center Industry/Academia Translational Oncology Symposium
ID
762914
Start date
25 Feb 2016
Location
La Jolla, California, United States
Abstract
The annual Industry/Academia Translational Oncology Symposium at Moores Cancer Center, now celebrating its 12th year, was created to support multi-modality collaborations and foster new partnerships in order to speed new therapies to patients. Each year the Symposium’s esteemed presenters from around the world, including clinicians, researchers, and top decision makers from industry and academia, attest to just how necessary it was for them to surmount multiple obstacles, in and out of the lab, in order to achieve success and help patients. The forum provides a platform for oncology innovators to highlight their interdisciplinary approach, as opposed to discussion on a specific type of cancer. Case study presentations showcase successful efforts, the challenges that they encountered, and the lessons they have learned from the process.
Contact
Leisa Sutton;     Phone: [858-822-6582];     Email: lsutton@ucsd.edu
Topics
Immunotherapy, Precision medicine, New therapeutic approaches in numerous cancers, Orphan drug oncology indications, Innovative clinical trial modalities, Funding innovation
Related subject(s)
9.
 
APBCS — 5th Asia-Pacific Breast Cancer Summit
ID
787933
Dates
26 Feb 2016 - 28 Feb 2016
Location
Singapore, United Arab Emirates
Abstract
Being one of the most common cancers in women, both in developed and underdeveloped regions of the world, there is a need to discuss the latest aspects of breast cancer and its alarming increase. During the past four years, the Asia Pacific Breast Cancer Summit has been successfully addressing vital topics regarding this prevalent disease. In 2016, the 5th Asia Pacific Breast Cancer Summit once again aims to bring together international & regional faculty experts in breast cancer to cover surgical, radiation and medical oncology related topics on early and advanced breast cancer management.
Contact
Kris Olarte;     Phone: [+97143116300];     Email: kris.olarte@mci-group.com
Topics
BreastCancer, Oncology
10.
 
Cancer Vaccines: Targeting Cancer Genes for Immunotherapy
ID
739968
Dates
06 Mar 2016 - 10 Mar 2016
Location
Whistler, Canada
Abstract
The past decade has seen tremendous developments in novel cancer therapies, through targeting of tumor cell-intrinsic pathways whose activity is linked to genetic alterations, as well as the targeting of tumor cell-extrinsic factors such as growth factors. Remarkable clinical success of checkpoint inhibitors as well as adoptively transferred genetically engineered T cells further demonstrates the critical role of T cells in cancer control and rejection. However, many patients still do not respond to checkpoint inhibitor therapies, possibly due to the lack of T cell repertoire with specificity against cancer antigens. This creates the need for effective means of expanding the T cells in patients via immunization, i.e., cancer vaccines. Much progress has been made in recent years in this regard, and several phase III clinical trials testing various approaches to therapeutic vaccination are ongoing. The challenge for next-generation vaccines is to resolve the discrepancy between the immune and clinical efficacy measured by the rate of cancer rejection. The future immunotherapy of cancer lies in combination approaches targeting T cells as well as cancer genes to combat underlying inflammation. Spectacular progress has been made in these two parallel fields, i.e., cancer genomics and genetics and tumor immunology. It is time now to link these fields to enable the linking of genetic alterations with the type of immune response. The meeting will therefore host cancer geneticists, cancer biologists, experts in cancer antigen presentation, tumor immunologists and vaccinologists. It will discuss the immunological basis for therapeutic cancer vaccines and how the current understanding of cancer genomics, antigen presentation and T cell biology might enable development of next-generation curative therapies for patients with cancer. This meeting will be held jointly with  Antibodies as Drugs.
11.
 
Antibodies as Drugs
ID
740126
Dates
06 Mar 2016 - 10 Mar 2016
Location
Whistler, Canada
Abstract
Monoclonal antibodies have had a pronounced impact in medicine and biology, with a broad array of approved agents that are used for the diagnosis, treatment and characterization of cancers, immunological disorders, and infectious diseases. Because of their exquisite target specificities, together with their favorable pharmacologic properties, antibodies are destined to have even increased clinical impact, particularly in diseases that are understood at the molecular level. This Keystone Symposia meeting will focus attention on many of the key advances in antibody-based technologies as well as on where the field is heading. Some of the critical topics to be covered include: 1) Antibody structure and function; 2) Engineered antibodies and antibody-like molecules for improved efficacy; 3) Antibody pharmacologic properties and biologic distribution; 4) Antibody-based therapies for cancer and infectious diseases; 5) Targeting costimulatory pathways and immunological checkpoints; 6) Antibodies as carriers of drugs, cytokines, radioisotopes and imaging agents; 7) Antibody mimetics; 8) Clinical advancements and challenges. This meeting has become an established forum that attracts both new investigators and leaders in the field, coming from academia, industry and research institutes around the globe. The goals of the meeting will be to address the critical issues facing the broad field of antibody-based therapeutics, provide an overview of recent advances and bring together interdisciplinary groups for the generation of new ideas and promising areas of investigation. This meeting is being held jointly with  Cancer Vaccines: Targeting Cancer Genes for Immunotherapy.
12.
 
Stem Cells and Cancer
ID
739971
Dates
06 Mar 2016 - 10 Mar 2016
Location
Breckenridge, United States
Abstract
Cancer stem cells have now been recognized in a wide variety of human tumors. The existence of cancer stem cells poses both tremendous challenges and tantalizing potential for our ability to successfully combat cancer. This Keystone Symposia meeting aims to bring together scientists who are interested in better understanding the mechanisms by which cancer stem cells contribute to tumor heterogeneity, self-renewal and drug resistance. One area of emphasis will be intercellular communication. Cellular context and microenvironment establish the tumor niche and shape the interaction of the tumor with the immune system. In addition, developmental signal transduction pathways such as Hippo, Notch and Wnt, frequently deregulated in cancer, increasingly offer tangible opportunities for therapeutic intervention. Another important area of emphasis will be efforts to better understand the mechanisms and importance of tumor heterogeneity. Techniques such as clonal analysis and barcoding are shedding important light on the interplay between tumor evolution, differentiation, miRNA control and epigenetics. This is an era of rapid progress in understanding cancer stem cell biology with great potential to benefit human health. 
Related subject(s)
13.
 
Training — Immuno-Oncology: An Introductory Overview
ID
791246
Start date
10 Mar 2016
Location
London, United Kingdom
Abstract
This one-day course provides an overview of the rapidly evolving subject of immuno-oncology. Delegates are offered a thorough understanding of the basics of tumour immunology as well as the essentials of immunotherapy and its application in cancer medicine. Examples of both how biologics work in the practice of oncology and of the challenges presented are demonstrated. The programme has been developed specifically to support the needs of pharmaceutical, biotechnology and medical technology industry personnel. It is ideal for individuals with little understanding of the immunotherapy of cancer and those with an existing basic knowledge. Detailed presentations and discussion with Healthcare’s experienced and knowledgeable faculty enable thorough insight to this important subject area.
Contact
Linda Merritt;     Phone: [01727 809917];     Email: courses@healthcare-ed.com
Topics
The immune system – a guide, Introduction to immunotherapies, Overview of Immunotherapy in Cancer, An Example in Practice – Lung Cancer, An Example in Practice – Melanoma
14.
 
PAIRS2016 — Pan Arab Interventional Radiology Society Annual Scientific Meeting 2016
ID
781291
Dates
10 Mar 2016 - 12 Mar 2016
Location
Dubai, United Arab Emirates
Abstract
The Pan-Arab Interventional Radiology Society (PAIRS) is rapidly growing society in the Middle East with a mission of spreading the latest endovascular, cardiovascular and interventional radiology technologies in the Middle East Region.

PAIRS is strongly committed to the principle of educational sessions leading the healthcare professionals to discuss and appreciate current and cutting edge technology and reach practical conclusions to help them in everyday practice. In this respect a three days’ meeting has been designed providing comprehensive case-based review and hands on experience covering topics in embolization, venous interventions, amputation prevention and neurointerventions.

The meeting is also a great opportunity to meet and network with colleagues in the field of IR. More than 500 healthcare professionals are expected to attend originating from the MENA region.

Contact
Basil Kadara;     Phone: [97144532975];     Email: contact@diaedu.com
Topics
Interventional Radiologists, Neuro Interventionalists, Vascular Surgeons, Cardiac Interventionists, Oncologists
Related subject(s)
Event website
15.
 
Changing Prospects for Cancer 'A good survival'
ID
737739
Start date
11 Mar 2016
Location
Manchester, United Kingdom
Abstract
Since the publication of the National Cancer Survivorship Initiative “Visioning” paper in 2010, the momentum behind improving  services for patients living with and beyond cancer has increased exponentially. The challenge for the next few years is to facilitate  implementation of these innovations into mainstream cancer services. In April 2014, The Christie, Macmillan Cancer Support and University  of Salford joined forces to hold a conference discussing and debating  the challenges, issues and controversies related to an increasing  population of cancer survivors. Join us on 11th March 2016 where  we will pick up the discussions at an interactive and discussion filled  conference
16.
 
BMP Signalling in Cancer
ID
784440
Dates
15 Mar 2016 - 17 Mar 2016
Location
Cambridge, United Kingdom
Abstract
The aim of this focused meeting is to explore the mechanisms of BMP signal transduction and regulation of signalling, and discuss how genetic and epigenetic alterations result in aberrant signalling and how this leads to cancer. The BMP signalling pathway is a key therapeutic target and we will consider how to manipulate the pathway with small molecules or biologics. This conference will bring together researchers from academe and industry, and will be a great opportunity for those working on BMP signalling, cancer, stem cells, structural biology and drug discovery to share data and interact in a vibrant, but informal environment.
Contact
Email: conferences@biochemistry.org
Topics
Mechanisms of BMP signalling Deregulation of BMP signalling in cancer and therapeutic approaches Genetic and epigenetic alterations in BMP pathway components BMP signalling in disease
Related subject(s)
17.
 
OeGHO- & AHOP-Frühjahrstagung 2016 — Frühjahrstagung 2016 der Österreichischen Gesellschaft für Hämatologie & Medizinische Onkologie und der AHOP - Arbeitsgemeinschaft hämatologischer und onkologischer Pflegepersonen in Österreich
ID
782622
Dates
17 Mar 2016 - 19 Mar 2016
Location
Vienna, Austria
Contact
Mondial Congress;     Phone: [0043 1 588 04 197];     Email: oegho2016@mondial-congress.com
Related subject(s)
18.
 
Biomarker Summit 2016
ID
744578
Dates
21 Mar 2016 - 23 Mar 2016
Location
San Diego, United States
Abstract
The Biomarker Summit 2016, to be held on March 21-23, 2016 in San Diego, CA at the Westin San Diego Hotel
Contact
Kristen Starkey;     Phone: [6262566405];     Email: infogtcbio@gtcbio.com
Topics
Oncology Biomarkers, Neurological Biomarkers, Inflammatory & Immunological Biomarkers
Related subject(s)
19.
 
Cancer Pathophysiology: Integrating the Host and Tumor Environments
ID
740003
Dates
28 Mar 2016 - 01 Apr 2016
Location
Breckenridge, United States
Abstract
The local and systemic tumor microenvironments (TME) play a pivotal role in all stages of cancer development, including initiation, malignant conversion and metastasis, as well as regulating how neoplastic cells respond to cytotoxic, targeted and immune-based therapies. Research over the last decade has revealed the incredible diversity and plasticity that constitute the TME. Thus, the focus of this meeting will be to bring together a wide breadth of experts who focus on the various aspects of the TME with the intent of creating a more complete picture of the potential therapeutic landscape. The unique feature of this meeting is its breadth of experts focused on both the systemic and local TME, who also recognize varied paracrine interactions with heterogeneous neoplastic cells. Presentations will focus on emerging studies to enable attendees access to senior investigators, as well as new investigators spanning the diversity of disciplines called “cancer biology.” In addition to invited speakers, time will be allotted for short oral presentations selected from submitted abstracts and three integrated poster sessions. 
20.
 
Oncology at the Limits 2016
ID
783078
Dates
31 Mar 2016 - 02 Apr 2016
Location
London, United Kingdom
Abstract
This scientific meeting is pan-tumor, a feature of the events which is always highly commended by delegates – please see the programme for full details of the presentations.
Contact
Marty Turner;     Phone: [01491419800];     Email: martyt@atthelimits.org
Topics
oncology, cancer immunotherapy, bladder cancer, breast cancer, T-cell mediated immunotherapies,
21.
 
EMBO | EMBL Symposium — EMBO | EMBL Symposium: Tumour Microenvironment and Signalling
ID
724214
Dates
03 Apr 2016 - 06 Apr 2016
Location
Heidelberg, Germany
Abstract
Many oncogenes and tumor suppressor genes have been identified and mapped to signaling pathways that regulate cell growth and death. Dysregulation allows oncogenes and tumor suppressor genes to transform mammalian cells and cancers arise in conditions where multiple such events occur in the same cell. Many proto-oncogenes and tumor suppressors have been mapped to canonical signaling pathways, providing a more holistic view of growth control mechanisms and paving the way for systems level analysis of cancer mechanisms.It has also been found that a subset of the cells present in a tumor, called cancer stem cells, retain the ability to self-renew and to give rise to all cell types in a particular cancer.

An emerging concept is that tumors also strongly depend on external signals for maintenance and expansion. To fully understand tumor development and progression, a deeper knowledge of the cross-talk between tumor cells and their microenvironment and the interactions between cancer cells and cancer stem cells is needed.

Aims of event

This symposium brings together researchers from complementing fields to enhance our understanding of the communication between cancer cells and their microenvironment. Important open questions are: Which signals do cancer cells transmit to and receive from the stroma and how do these signals promote malignant growth? What roles does the extracellular matrix play during neoplastic transformation? What is the contribution of immune cells to tumor progression? How is the inflammatory response of the tumor microenvironment regulated by the microbiota?

Contact
Email: carolina.sabate@embl.de
Topics
Signalling pathways in stroma and cancers, Cancer stem cells, Cancer and the immune system, Animal models of cancer, Therapeutical implications: from bench to bedside
Related subject(s)
22.
 
Cancer-2016 — International Cancer Study & Therapy Conference
ID
742866
Dates
04 Apr 2016 - 06 Apr 2016
Location
Baltimore, United States
Abstract
International Cancer Study & Therapy Conference (Cancer-2016) is going to be held during April 4-6, 2016 at Baltimore, USA. Cancer 2016 bring upon a new platform to share and discuss all the innovations in the cancer diagnosis and treatment.
Contact
Jennifer Roy;     Phone: [+1-302-231-6959];     Email: cancer@madridge.com
Topics
Cancer Etiology and Epidemiology • Organ Specific Cancers and Effects • Clinical Research • Vaccines and Cancer Prevention Mechanisms • Cancer Immunology • Cancer Genetics Risk Assessment • Radiation, Surgical and Medical oncology • Structural Biology and Biomarkers • Diagnostic methods for cancer treatment Please mail us at: cancer@madridge.com Submit your abstracts at: http://cancer.madridge.com/abstract.php
23.
 
MDXE — Molecular Diagnostics Europe
ID
784815
Dates
04 Apr 2016 - 07 Apr 2016
Location
LIsbon, Portugal
Abstract
Novel molecular-based tools are rapidly entering the clinic and creating a new paradigm in healthcare. The Fourth International Molecular Diagnostics Europe event will return to Lisbon this spring and feature six tracks: Prenatal Molecular Diagnostics, Reproductive Genetic Diagnostics, Circulating Tumour Cells, Circulating Cell-Free DNA, Advanced Diagnostics for Infectious Disease, and Point-of-Care Diagnostics. As the prenatal diagnostics market has demonstrated, molecular diagnostics are being applied to the clinical setting for greater speed and accuracy of healthcare delivery, while paving the way for a new era in medicine.
Contact
Phone: [7819725400];     Email: chi@healthtech.com
Topics
reproductive genetics, circulating tumor cells, point-of-care diagnostics, molecular diagnostics, prenatal, infectious disease
24.
 
Training — Immuno-Oncology: An Introductory Overview
ID
791349
Start date
06 Apr 2016
Location
Newark, NJ, United States
Abstract
This one-day course provides an overview of the rapidly evolving subject of immuno-oncology. Delegates are offered a thorough understanding of the basics of tumor immunology as well as the essentials of immunotherapy and its application in cancer medicine. Examples of both how biologics work in the practice of oncology and of the challenges presented are demonstrated. The programme has been developed specifically to support the needs of pharmaceutical, biotechnology and medical technology industry personnel. It is ideal for individuals with little understanding of the immunotherapy of cancer and those with an existing basic knowledge. Detailed presentations and discussion with Healthcare’s experienced and knowledgeable faculty enable thorough insight to this important subject area.
Contact
Linda Merritt;     Phone: [+44 727 809917li];     Email: courses@healthcare-ed.com
Topics
The immune system – a guide, Introduction to immunotherapies, Overview of Immunotherapy in Cancer, An Example in Practice – Lung Cancer, An Example in Practice – Melanoma
25.
 
26th Annual Interdisciplinary Breast Center Conference
ID
760807
Dates
09 Apr 2016 - 13 Apr 2016
Location
Las Vegas, United States
Contact
Michelle Dearlove;     Phone: [(574-401-8113)];     Email: michelle@breastcare.org
Related subject(s)
26.
 
APOCP — General Assembly and International Conference of Asian Pacific Organisation for Cancer Prevention
ID
650963
Dates
13 Apr 2016 - 16 Apr 2016
Location
Brisbane, Australia
Abstract
Asian Pacific Organisation for Cancer Prevention (APOCP) is a non-political, non-profit organisation to promote cancer prevention and collaborative studies in the Asia Pacific region. The aims of APOCP are to provide opportunities for expert researchers to exchange mutual information for cancer prevention, to promote collaborative studies on cancer epidemiology and prevention, and to facilitate the implementation of active programs for cancer prevention. The General Assembly and Conference is APOCP’s regional biennial summit, drawing highly influential delegates together to guide the organisation’s action agenda.
Event website
27.
 
AACR Annual Meeting
ID
615315
Dates
16 Apr 2016 - 20 Apr 2016
Location
New Orleans, Louisiana, United States
Event website
28.
 
Oncology-2016 — World Congress and Expo on Oncology & Radiology
ID
766113
Dates
18 Apr 2016 - 20 Apr 2016
Location
Dubai, United Arab Emirates
Contact
Vijay Kumar;     Phone: [7799790001];     Email: oncology.conference@scientificfederation.com
Topics
Cancer Cell Biology & Biomarkers, Advances in Cancer Detection, Imaging, Management & Prevention, Organ-Specific Cancers and Cancer Genetics, Anti-Cancer Drug Discovery and Development, Novel Approaches to Cancer Therapeutics, Cancer Therapy and Clinical Cancer Research, Socio-Economic Impact of Cancer, Ayurvedic Treatment for Cancer
29.
 
Training — Introduction to Oncology and Cancer Treatment
ID
791228
Dates
20 Apr 2016 - 21 Apr 2016
Location
London, United Kingdom
Abstract
Delegates attending this course benefit from an introductory overview of the terminology and classification of cancer and the principle issues in its treatment. The issues of oncology clinical trials will be discussed. Commonly available anti-cancer drugs are reviewed with emphasis on mode of action, dose intensity and chemotherapy regimes. Immunotherapies will be given particular focus. Detailed consideration is given to the treatment of major tumour types; breast, lung, upper gastrointestinal (GI), colorectal, ovarian, and skin cancer focusing on melanoma. Each session is presented by clinicians active in these areas and will focus on overall patient presentation and management, cancer diagnosis and staging. Following each session, our experts will lead delegates in interactive group discussions on the key issues relating to effective management of each tumour type.
Contact
Linda Merritt;     Phone: [01727 809917];     Email: courses@healthcare-ed.com
Topics
oncology, cancer
30.
 
Cancer and Autoimmunity 2016 — Emerging Target Therapies in Cancer & Autoimmunity
ID
738405
Dates
21 Apr 2016 - 25 Apr 2016
Location
Varadero, Cuba
Abstract
The four-day event will bring together basic scientists, medicinal chemists, pharmacologists, biotechnologists, clinical investigators, and other allied professionals from around the world, interested in the fields of disease pathogenesis and new targeted therapies development for Cancer and for Autoimmune Disorders. The meeting will be an excellent opportunity to expose the translational nature of modern biomedical and pharmaceutical research.

One of the key objectives of the 2016 Symposium will be to arm delegates with the necessary tools that will enable them to make a difference, implement and take actions at all levels, in global fight against cancer or autoimmunity diseases.

Contact
Jesus Benitez;     Email: biomed@cigb.edu.cu
Topics
Molecular oncology; Tumor immunology; Cancer Immunotherapy, Clinical trials; Mechanisms of autoimmune-related diseases; Regulatory T cells and autoimmunity; Pharmacological strategies for treatment
31.
 
Cilia, Cytoskeleton and Cancer
ID
784470
Dates
25 Apr 2016 - 26 Apr 2016
Location
Edinburgh, United Kingdom
Abstract
Emerging research has provided evidence of a fundamental link between cytoskeletal structures such as centrioles and cilia in the regulation of DNA repair and genomic instability.

This is highlighted by an increasing number of cancers/syndromes with clear ciliary connections such as Birt-Hogg-Dube syndrome, Von Hippel-Lindau disease and Tuberous Sclerosis. Not only do cilia normally regulate many of the cellular signalling pathways commonly perturbed in cancer, but the ability to form cilia is lost in many transformed cells and it has been shown that the primary cilium can both mediate and suppress Hedgehog pathway-dependent tumourigenesis.

As the pivotal link between tumourigenesis and cilia function is emerging, this meeting will represent a timely opportunity to bring together researchers from the fields of cancer and cytoskeletal/cilia biology.

The format will allow invitation of speakers in cilia and cytoskeletal biology and speakers with specific interest in how these cellular processes influence the carcinogenesis process. Structured thematic sessions with talks describing fundamental cellular processes in cilia, cytoskeletal and tumour biology and how dysregulation of these processes can initiate disease, will culminate with talks aimed at the interplay between cilia, cytoskeleton and cancer and how these processes can be targeted therapeutically.

Contact
Email: conferences@biochemistry.org
Topics
Signalling pathways, Cilia and cancer, Ciliopathies, Cytoskeleton and cancer
Related subject(s)
32.
 
Training — Introduction to Cancer: Focus on Solid Tumors
ID
791271
Dates
27 Apr 2016 - 28 Apr 2016
Location
Newark, NJ, United States
Abstract
Delegates attending this course benefit from an introductory overview of the terminology and classification of cancer and the principle issues in its treatment. Commonly available anti-cancer drugs will be reviewed, including immunotherapies. The range of side-effects of cancer treatments will be studied in detail. Quality of life issues in terms of overall assessment and result interpretation are discussed too.
Contact
Linda Merritt;     Phone: [+44 1727 809917];     Email: courses@healthcare-ed.com
Topics
Cancer: terminology and classification, Introduction to anti-cancer drugs and side effects, New developments in cancer therapy, Introduction to the major tumor types: breast, lung, melanoma, upper GI, colorectal, ovarian and prostate cancer, Clinical trial issues in oncology
33.
 
The 2nd World Congress on Controversies in Multiple Myeloma (COMy)
ID
757159
Dates
28 Apr 2016 - 30 Apr 2016
Location
Paris, France
Abstract
The 2nd COMy Congress will bring to the forefront the latest and most controversial data and information in the field of Multiple Myeloma, providing a unique opportunity for world class leaders in the field to debate vital and contentious issues in Myeloma. This thought-provoking academic dialogue will address the most challenging current clinical and therapeutic questions.
Contact
Natalie Ross;     Phone: [97235666166];     Email: comy@comtecmed.com
Topics
Myeloma, Oncology, Hematology, Therapy, Treatment
Related subject(s)
34.
 
APGCS — Asia Pacific Gastroenterology Summit 2016
ID
787404
Dates
29 Apr 2016 - 01 May 2016
Location
Bangkok, Thailand
Abstract
The conference will encompass malignancies affecting every component of the gastrointestinal tract and aspects related to the care of patients with gastrointestinal cancer, including screening, diagnosis and the latest management options for common and uncommon tumours. The conference will educate and update delegates who participate in the treatment of gastrointestinal cancers, providing a clear overview for treatment.
Contact
Praha;     Phone: [+971 4 311 6300];     Email: apgcs@mci-group.com
Topics
oncology gastroenterology
Related subject(s)
Event website
35.
 
ESTRO 35
ID
783208
Dates
29 Apr 2016 - 03 May 2016
Location
Lingotto Fiere, Via Nizza, 294 , Turin, 10126, Italy
Abstract
ESTRO 35 will draw attention to the multidisciplinarity and interdisciplinary components of Radiation Oncology
Contact
Sonia Marques;     Phone: [0032-027759343];     Email: smarques@estro.org
Topics
radiation oncology
36.
 
6th International Symposium on Hereditary Breast and Ovarian Cancer
ID
727494
Dates
10 May 2016 - 13 May 2016
Location
Montreal, Canada
Abstract
“BRCA: Challenges and Opportunities – the Sixth International Symposium of Hereditary Breast and Ovarian Cancer ” represents a unique opportunity to look at all aspects of breast and ovarian cancer, and in particular the susceptibility genes, BRCA1 and BRCA2, which are responsible for a considerable fraction of early-onset breast cancer.      It is an accredited continuing educational activity for physicians and genetic counselors.   This is THE major international conference in the world that covers specific targeted therapies for hereditary cancer. Clinicians and researchers from over 25 countries will gather for the sixth edition of this event which has come to be recognized as one of the leading international scientific conferences on hereditary breast and ovarian cancer.
37.
 
Controlling Cancer Summit 2016
ID
737322
Dates
17 May 2016 - 19 May 2016
Location
London, United Kingdom
Abstract
The annual Controlling Cancer Summit in an international academic event with plenty of opportunity  for networking and debate. In an informal setting, this meeting will bring you up to date with current research and thinking regarding screening, prevention and treatment in  this ever-growing field.  Presenting at this event, we will have a variety of clinicians, academics and members of the pharmaceutical industry; we encourage presentations from  the wide spectrum of cancer research, development and healthcare professionals.
38.
 
EMBO Conference — Cellular signalling and cancer therapy
ID
739271
Dates
27 May 2016 - 31 May 2016
Location
Cavtat, Croatia
Topics
Signal Transduction | Molecular Medicine
Related subject(s)
39.
 
American Society of Clinical Oncology 2016 Annual Meeting
ID
651301
Dates
03 Jun 2016 - 07 Jun 2016
Location
Chicago, United States
Abstract
Attendees of the 2016 Annual Meeting will find cutting-edge scientific presentations and comprehensive educational content. The ASCO Annual Meeting brings together more than 25,000 oncology professionals from a broad range of specialties, making it an excellent venue for exploring the theme of the Meeting — "Science and Society." Prospective attendees can familiarize themselves with some basic information, including: The various session types that will take place at the Annual Meeting, The Cancer Education and Scientific Program Committees.
Event website
40.
 
FASEB Cell Signaling in Cancer: from Mechanisms to Therapy
ID
785910
Dates
05 Jun 2016 - 10 Jun 2016
Location
Snowmass Village, CO, United States
Abstract
This FASEB Science Research Conference focuses on understanding the molecular and cellular mechanisms of signaling in cancer in order to develop effective therapies. Specifically, the driving force behind this meeting is that understanding cancer at the molecular and cellular level opens the arena for novel therapeutic strategies. The meeting will cover cancer from the biochemical to the therapeutic level. Focus on genomics, spatial aspects of signaling, and patient data will be a new strength of the meeting, which formerly focused on lipid signaling in cancer. This conference broadens the mechanistic/biochemical aspect historically represented at the meeting to cover all signaling pathways relevant to developing therapies for cancer. The conference will provide ample opportunities for informal interaction to foster collaboration and promote the exchange of ideas
Contact
FASEB SRC Staff;     Phone: [301.634.7010];     Email: src@faseb.org
Related subject(s)
41.
 
IARC 50th Anniversary Conference
ID
739817
Dates
07 Jun 2016 - 10 Jun 2016
Location
Lyon, France
Abstract
A scientific conference to celebrate the 50th anniversary of the International Agency for Research on Cancer In keeping with IARC’s mission over the past five decades, this anniversary conference will feature presentations on research into the global occurrence, etiology, and prevention of cancer as well as the implementation of prevention and early detection. The multidisciplinary conference will bridge cancer research through to cancer control and policy, providing comprehensive state-of-the-art summaries from keynote speakers as well as a look forward at future research priorities.
42.
 
RBSS 2016 — ROME BREAST SURGERY SYMPOSIUM
ID
783008
Dates
08 Jun 2016 - 10 Jun 2016
Location
Rome, Italy
Abstract
The Congress is characterized by a multidisciplinary structure, covering different aspects: from diagnose to therapy, to reconstructive surgery in breast cancer.
Contact
Alfa FCM Srl;     Phone: [+39 06 87757099];     Email: secretariat@romebreastsurgery.it
Topics
BREAST, SURGERY, ROME, SYMPOSIUM, NURSING, CARDIO-THORACIC, OBSTETRIC, GYNAECOLOGY, ONCOLOGY, REHABILITATION, AESTHETIC
Related subject(s)
43.
 
DEGRO 2016 — 22. Jahrestagung der Deutschen Gesellschaft für Radioonkologie – Unter Mitwirkung der Österreichischen Gesellschaft für Radioonkologie, Radiobiologie und medizinische Radiophysik (ÖGRO)
ID
771623
Dates
16 Jun 2016 - 19 Jun 2016
Location
Mannheim, Germany
Abstract
MOTTO KONGRESS 2016: INNOVATIONEN FÜR PATIENTEN

Innovationen für Patienten stehen wie in kaum einer anderen Fachdisziplin im Zentrum unserer täglichen klinischen Arbeit und unserer wissenschaftlichen Anstrengungen. Die Radioonkologie hat sich in den letzten Jahren unglaublich dynamisch entwickelt. Gemeinsam mit unseren Kollegen von der ÖGRO wollen wir unsere neuesten Forschungsergebnisse präsentieren, Zukunftsentwicklungen diskutieren und den kollegialen Austausch pflegen.

Contact
Annika Bleckert;     Phone: [004930204590];     Email: degro@mci-group.com
Topics
oncology, radiology
Related subject(s)
44.
 
Regulatory Myeloid Suppressor Cells: From Basic Discovery to Therapeutic Application
ID
791399
Dates
16 Jun 2016 - 19 Jun 2016
Location
Philadelphia, Pennsylvania, United States
Abstract
The Regulatory Myeloid Suppressor Cells: From Basic Discovery to Therapeutic Application conference will focus on the pathological functions of myeloid-derived suppressor cells, dendritic cells, macrophages and neutrophils, and provide a forum for in-depth discussion of the most pressing issues associated with the biology and clinical application of these cells. The conference will bring together scientists from academia and industry interested in the basic and translational aspects of these cells in cancer and other pathological conditions. The agenda includes plenary sessions, which combine presentations from invited speakers and those selected from submitted abstracts, and poster sessions, where the most recent data will be discussed.
Contact
Catherine Michalski;     Phone: [215-495-6928];     Email: cmichalski@wistar.org
Topics
immunology, oncology, immunotherapeutics, basic science
45.
 
FOCAL 2016 — 9th International Symposium on Focal Therapy and Imaging in Prostate & Kidney Cancer
ID
787292
Dates
23 Jun 2016 - 25 Jun 2016
Location
Washington Duke Inn Hotel, Durham, North Carolina, United States
Abstract
The 9th International Symposium on Focal Therapy and Imaging in Prostate & Kidney Cancer is presented by Duke University Medical Center, Durham, North Carolina, USA in collaboration with AMC University Hospital, Amsterdam, The Netherlands and USC Institute of Urology, Los Angeles CA, USA. In June 2016 it will have been nine years since the initiation of the first International Symposium on Focal Therapy and Imaging in Prostate & Kidney Cancer, which rotates between USA and Amsterdam each year.
Contact
Email: focal@focaltherapy.org
Topics
Urology, Prostate Cancer, Kidney Cancer, Laser Therapy, Cryosurgery, Photodynamic Therapy, High-Intensity Focused Ultrasound, Photodynamic Therapy, Irreversible Electroporation, Robotic Diagnostic, Therapeutic Platforms, Stereotactic Treatment, Image Guided Diagnosis, Image Guided Interstitial Laser Therapy, Image Guided Follow
Related subject(s)
46.
 
WIN symposium 2016
ID
760139
Dates
27 Jun 2016 - 28 Jun 2016
Location
Paris, France
Abstract
The Worldwide Innovative Networking (WIN) Consortium invites you to join the WIN 2016 Symposium, to be held in Paris, June 27-28, 2016. This Symposium will be the next in the successful series of annual meetings dedicated to precision cancer medicine.
47.
 
OIC 2016 — ONCOLOGIC IMAGING COURSE 2016
ID
773903
Dates
30 Jun 2016 - 02 Jul 2016
Location
Dubrovnik, Croatia
Contact
Ana Krasevac;     Phone: [+3851 4550 335];     Email: office@oncoic.org
Event website
48.
 
EACR24 — 24th Biennial Congress of the European Association for Cancer Research
ID
772649
Dates
09 Jul 2016 - 12 Jul 2016
Location
Manchester, United Kingdom
49.
 
FASEB SRC: Phospholipid Signaling in Cancer, Neurodegeneration and Cardiovascular Disease
ID
786091
Dates
31 Jul 2016 - 05 Aug 2016
Location
Steamboat Springs, Colorado, United States
Abstract
This FASEB Science Research Conference focuses on new developments in the biology of lipid signaling with an emphasis on cancer, neuronal and cardiovascular diseases. The emphasis will be on molecular, cellular, structure/function and enzymatic mechanisms of physiological signaling pathways and how defects in these pathways contribute to the biology and pathophysiology of cancer, neurodegeneration and cardiovascular disease.The 2016 meeting brings together a wide range of leading investigators from across the globe. The scope of their subjects is vast, encompassing studies at the level of single proteins as well as the pathophysiology of complex disease. The program will highlight inter-disciplinary approaches and how major advances in biophysical, proteomic, genomic, imaging, modeling and therapeutic approaches are driving the field. The discussion forums and recreational activities will provide all participants extensive opportunities to exchange new ideas and forge new collaborations in a supportive interdisciplinary environment for participants at all stages of their research profession.
Contact
FASEB SRC Staff;     Phone: [3016347010];     Email: SRC@faseb.org
Related subject(s)
50.
 
WCCS 2016 — 16th World Congress on Cancers of the Skin and the 12th Congress of the European Association of Dermato-Oncology
ID
784336
Dates
31 Aug 2016 - 03 Sep 2016
Location
Vienna, Austria
Abstract
The 16th World Congress on Cancers of the Skin will be held in Vienna, Austria, from August 31 – September 3, 2016. Participating in this extraordinary scientific event offers physicians a unique opportunity to interact with distinguished international faculty and learn about breakthrough discoveries in the prevention, diagnosis and treatment of all types of skin cancer. The program will highlight melanomas and non-melanomas, new advances in diagnosis, and new perspectives in the treatment of skin cancer. The scientific program structure includes symposiums, forums, conferences and round table discussions.
Contact
Astrid Wilch;     Phone: [004930204590];     Email: wccs2016@mci-group.com
Related subject(s)
Event website
51.
 
SOHO 2016 — Society of Hematologic Oncology Fourth Annual Meeting
ID
764363
Dates
07 Sep 2016 - 10 Sep 2016
Location
Houston, Texas, United States
Abstract
The Society of Hematologic Oncology Fourth Annual Meeting is scheduled for September 7-10, 2016 at the Westin Galleria and Oaks in Houston, Texas.
Contact
Melinda White;     Phone: [1 (281) 364-7387 ext 216];     Email: mwhite@jwccinc.com
Topics
hematology, oncology, soho, hematologic malignancies, society of hematologic oncology
Related subject(s)
Event website
52.
 
ESGO2016 SoA — ESGO 2016 State of the Art Gynaecological Oncology Conference
ID
784186
Dates
08 Sep 2016 - 10 Sep 2016
Location
Antalya, Turkey
Abstract
The European Society of Gynaecological Oncology (ESGO) reveals the latest clinical and research developments in Gynaecological Cancers prevention at ESGO 2016 Conference, Sep 08-10, Antalya, Turkey.
Contact
Alexandra Ospanova;     Email: alexandra.ospanova@esgomail.org
Topics
gynaecological cancer, cervical cancer, ovarian cancer, endometrial cancer, cancer prevention, cancer screening, hpv
Related subject(s)
53.
 
CoBrCa — 2nd World Congress on Controversies in Breast Cancer
ID
765269
Dates
08 Sep 2016 - 11 Sep 2016
Location
Barcelona, Spain
Abstract
CoBRCA will continue the tradition of directly addressing controversial issues in breast cancer faced by clinicians in their daily practice. The congress will address these key issues in the format of debates and discussions, allowing ample time for speaker-participant interaction. In addition to the key issues in medical oncology, surgery, radiation oncology and supportive care, CoBrCa will address controversial issues in radiology, pathology and reconstruction, with presentations, debates and discussions.
Contact
Ilana Rabinoff-Sofer;     Phone: [+972 73 706 6954];     Email: cobrca@congressmed.com
Topics
breast cancer, oncology
54.
 
36th Congress of the European Society of Surgical Oncology (ESSO36) in partnership with the Polish Society of Surgical Oncology
ID
773307
Dates
14 Sep 2016 - 16 Sep 2016
Location
Cracow, Poland
Abstract
ESSO 36   builds on the success of previous congresses, lauded for top-quality scientific programmes and exceptional speakers, by providing delegates with unique educational opportunities and a platform to interact and establish new collaborations. The latest developments and key issues in surgical oncology will be discussed through an array of interactive sessions to highlight the significance of a multidisciplinary approach for management of cancer patient care. This Congress will focus on bridging the disparity between minimum standards of care across Europe and the overarching theme of the Congress is   ‘Optimising European Cancer Surgery’.   will provide all the ingredients for an outstanding scientific, educational and networking event.
Related subject(s)
55.
 
Training — Oncology Trials: Focus on Phase III
ID
791255
Dates
05 Oct 2016 - 06 Oct 2016
Location
London, United Kingdom
Abstract
This interactive and informative course provides a comprehensive overview of the planning and implementation of oncology clinical trials, focusing on Phase III. The course will demonstrate how oncology trials differ in design and conduct from those in other therapy areas. Delegates can learn to design trials to minimise the deficiencies that lead to inappropriate interpretation whilst maximising the competitive advantage. Delegates will hear the perspective of currently practicing oncologists with extensive experience of industry clinical trials as well as professionals who will discuss oncology clinical trial statistics and oncology product market entry.
Contact
Linda Merritt;     Phone: [01727 809917];     Email: courses@healthcare-ed.com
Topics
Why Are Cancer Trials Different?, Introduction to oncology clinical trial design, Translational Studies in Phase III Trials, Designing Clinical Trials to Impact on Clinical Practice, Statistical analysis and reporting of clinical trials, Quality of life assessment, Other Methods Used for Statistics in Clinical Trials, Planning for Market Access
Related subject(s)
56.
 
ESMO 2016 Congress
ID
760765
Dates
07 Oct 2016 - 11 Oct 2016
Location
Copenhagen, Denmark
Abstract
The annual ESMO Congress is the premier scientific platform to present your oncology research and as such, the ultimate learning experience for Congress attendees. Across disciplines and across cultures, ESMO bridges the gap between researchers, clinicians and patients and unites all stakeholders focused on finding the most effective cancer treatment solutions available today.
57.
 
Hämato/Onko Refresher, Berlin
ID
786430
Dates
04 Nov 2016 - 05 Nov 2016
Location
Adlershof con.vent. - Veranstaltungszentrum (Bunse, Germany
Contact
Christin Rasper;     Phone: [+49 (0) 6192 957 89 -41];     Email: info@fomf.de
Topics
Refresher, Hämatologie, Onkologie, Fortbildung
Related subject(s)
Event website
58.
 
Hämato/Onko Refresher, Köln
ID
786484
Dates
11 Nov 2016 - 12 Nov 2016
Location
KOMED im MediaPark GmbH, Im MediaPark 7, 50670 -, Germany
Contact
Christin Rasper;     Phone: [+49 (0) 6192 957 89 -41];     Email: info@fomf.de
Topics
Refresher, Hämatologie, Onkologie, Fortbildung
Related subject(s)
Event website
59.
 
Molecular and Cellular Basis of Breast Cancer Risk and Prevention
ID
781736
Dates
12 Nov 2016 - 15 Nov 2016
Location
United States, United States
Abstract
The goals for the program are to inspire important insights, energise new scientists and foster creative collaborations that will deepen our understanding of the molecular events underlying breast cancer initiation and accelerate the development of targeted prevention and early detection strategies.
Related subject(s)
60.
 
Hämato/Onko Refresher, Stuttgart
ID
786461
Dates
25 Nov 2016 - 26 Nov 2016
Location
GENO Haus Stuttgart, Heilbronner Str. 41, 70191 -, Germany
Contact
Christin Rasper;     Phone: [+49 (0) 6192 957 89 -41];     Email: info@fomf.de
Topics
Refresher, Hämatologie, Onkologie, Fortbildung
Related subject(s)
Event website
61.
 
28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
ID
773640
Dates
28 Nov 2016 - 02 Dec 2016
Location
Munich, Germany
Abstract
It is our great pleasure to announce that the   28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics   will take place in Munich.  Hosted by the European Organisation for Research and Treatment of Cancer (EORTC), the National Cancer Institute (NCI) and the American Association for Cancer Research (AACR), the 2016 Symposium will bring together around 2000 academics, scientists and pharmaceutical industry representatives from across the globe to discuss innovations in drug development, target selection and the impact of new discoveries in molecular biology. As a one-of-a-kind Symposium at the forefront of drug development, it will enable participants to apply the latest findings and knowledge in their work and practice. This edition will also build on the success of the previous symposium which was widely praised for the quality of its programme, inspirational contributions and exclusive insights.
62.
 
17th World Conference on Lung Cancer 2016
ID
649324
Dates
04 Dec 2016 - 07 Dec 2016
Location
Vienna, Austria
Abstract
The World Conference on Lung Cancer (WCLC) is the world’s largest meeting dedicated to lung cancer and other thoracic malignancies. More than 7,000 delegates come from more than 100 countries to discuss the latest developments in thoracic malignancy research. Attendees include surgeons, medical oncologists, radiation oncologists, pulmonologists, radiologists, pathologists, epidemiologists, basic research scientists, nurses and allied health professionals and patients. 
Related subject(s)
63.
 
Cell Symposia: Hallmarks of Cancer
ID
761493
Dates
11 Dec 2016 - 13 Dec 2016
Location
Ghent, Belgium
Abstract
As one of the most investigated areas in biomedical research, the cancer field is rapidly advancing by translating biological insights towards better detection and therapeutics, including molecular classifications as well as immunotherapies. In the era of the genetically informed, emerging concepts in cancer biology and oncology research are colliding into precision medicine. In order to accelerate the development of personalized cancer therapies and further translate fundamental discoveries into the clinic, there must be open lines of communication at the interface between the lab and the clinic. Our goal in organizing this Cell Symposium, Hallmarks of Cancer, is to convene global leaders in the cancer research arena to enhance our understanding of the key aspects of cancer and how to promote translation of this knowledge into the development of targeted therapeutics. We aim to provide a high-impact, high-profile forum for exchanging ideas and establishing a dialogue amongst clinicians, scientists and drug development companies. Symposium themes: Tumor metabolism, Tumor heterogeneity, Tumor immunology and immunotherapy, Personalized cancer therapy, Metastasis and the tumor microenvironment.
Related subject(s)
64.
 
Cancer Conference
ID
781848
Dates
24 Feb 2017 - 27 Feb 2017
Location
Carlsbad, United States
65.
 
American Society of Clinical Oncology 2017 Annual Meeting
ID
651344
Dates
02 Jun 2017 - 06 Jun 2017
Location
Chicago, United States
Abstract
Attendees of the 2017 Annual Meeting will find cutting-edge scientific presentations and comprehensive educational content. The ASCO Annual Meeting brings together more than 25,000 oncology professionals from a broad range of specialties, making it an excellent venue for exploring the theme of the Meeting — "Science and Society." Prospective attendees can familiarize themselves with some basic information, including: The various session types that will take place at the Annual Meeting, The Cancer Education and Scientific Program Committees.
Event website
66.
 
Joint meeting of the 9th World Congress of Melanoma and 14th International Congress of the Society for Melanoma Research
ID
764479
Dates
18 Oct 2017 - 21 Oct 2017
Location
Brisbane, Australia
Contact
Vivien Lietze;     Phone: [+4930204590];     Email: congress@worldmelanoma2017.com
Topics
Dermatology, Dermato-Oncology, Skin-Cancer, Melanoma
Related subject(s)

Good to know...

You can advertise your event or services in this space.

Last updated: 30 October 2097